Diarylheptanoid hirsutenone enhances apoptotic effect of TRAIL on epithelial ovarian carcinoma cell lines via activation of death receptor and mitochondrial pathway

Current strategies to target p53 in cancer

(2010) Fang Chen et al.   BIOCHEMICAL PHARMACOLOGY

Cell death mechanisms: Cross-talk and role in disease

(2010) Boris Zhivotovsky et al.   EXPERIMENTAL CELL RESEARCH

Hirsutenone inhibits lipopolysaccharide-activated NF-κB-induced inflammatory mediator production by suppressing Toll-like receptor 4 and ERK activation

(2010) Chung Soo Lee et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

TRAIL as a target in anti-cancer therapy

(2009) Gen Sheng Wu   CANCER LETTERS

Bax activation by Bim?

(2009) P E Czabotar et al.   CELL DEATH AND DIFFERENTIATION

Death receptors: Targets for cancer therapy

(2009) Zafar Mahmood et al.   EXPERIMENTAL CELL RESEARCH

Diarylheptanoid hirsutenone prevents tumor necrosis factor-α-stimulated production of inflammatory mediators in human keratinocytes through NF-κB inhibition

(2009) Chung Soo Lee et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Apoptotic mechanisms involved in neurodegenerative diseases: Experimental and therapeutic approaches

(2009) A. Camins et al.   METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

Cytotoxic activities of diarylheptanoids from Alnus japonica

(2008) Sun Eun Choi et al.   ARCHIVES OF PHARMACAL RESEARCH